|
| Status |
Public on Nov 19, 2014 |
| Title |
clone #11, R140Q, DMSO, 28 days [23] |
| Sample type |
genomic |
| |
|
| Source name |
clone #11, R140Q, DMSO, 28 days
|
| Organism |
Homo sapiens |
| Characteristics |
construct: R140Q
treatment: DMSO
days: 28
clone_number: 11
barcode: 8221916163_R05C01
cell type: TF-1 cells
|
| Treatment protocol |
Varies
|
| Growth protocol |
Cell culture with varying growth times
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
genomic DNA was extracted using Qiagen DNeasy Kit according to standard instructions
|
| Label |
Cy5 and Cy3
|
| Label protocol |
Standard Illumina Protocol
|
| |
|
| Hybridization protocol |
bisulphite converted DNA was amplified, fragmented and hybridised to Illumina Infinium Human Methylation450 Beadchip using standard Illumina protocol
|
| Scan protocol |
Arrays were imaged using BeadArray Reader using standard recommended Illumina scanner setting
|
| Description |
23
|
| Data processing |
BeadStudio software v3.2 was used to export data to Partek Genomics Suite Format
|
| |
|
| Submission date |
Oct 17, 2013 |
| Last update date |
Nov 19, 2014 |
| Contact name |
Andrew Kernytsky |
| Organization name |
Agios
|
| Street address |
38 Sidney St
|
| City |
Cambridge |
| State/province |
Massachusetts |
| ZIP/Postal code |
02139 |
| Country |
USA |
| |
|
| Platform ID |
GPL13534 |
| Series (1) |
| GSE51352 |
IDH2 mutation induced histone and DNA hypermethylation is progressively reversed by small molecule inhibition |
|
